Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 8

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 8
---
1” or, the “Issuance Proposal”); |

| 2. | the                                                                                           
 approval of an amendment to our Amended and Restated Certificate of Incorporation, as amended 
 (the “Charter”) to effect, at the discretion of the Board but prior to the one-year           
 anniversary of the date on which the reverse stock split is approved by the Company’s         
 stockholders at the Special Meeting, a reverse stock split of all of the outstanding shares   
 of our Common Stock at a ratio in the range of 1-for-250 to 1-for-500, with such ratio to     
 be determined by the board of directors of the Company in its discretion and included in      
 a public announcement (“Proposal 2” or, the “Reverse Stock Split Proposal”);                  |

<div align='center'>1</div>

| 3. | the approval of the Third Amendment to the Petros Pharmaceuticals, Inc.                                                              
 Amended and Restated 2020 Omnibus Incentive Compensation Plan, as amended, to increase the total number of shares of the Company’s   
 Common Stock authorized for issuance under such plan by 1,000,000,000, to a total of 1,002,760,000 shares of Common Stock (“Proposal 
 3” or, the “Plan Amendment Proposal”);                                                                                               |

| 4. | the approval of an amendment to the Charter, to increase the number                                                                       
 of our authorized shares of Common Stock from 250,000,000 shares to 7,000,000,000 shares and to make a corresponding change to the number 
 of authorized shares of capital stock (“Proposal 4” or, the “Share Increase Proposal”); and                                               |

| 5. | the approval of a proposal to adjourn the Special Meeting to a later                                                                    
 date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient 
 votes for, or otherwise in connection with, the approval of any one or more of the foregoing proposals (“Proposal 5” or, the            
 “Adjournment Proposal”).                                                                                                                |

The Board unanimously recommends that you vote “FOR” proposals 1, 2, 3, 4 and 5.

<div align='center'>2

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</div>

Disclosures in this Proxy Statement may contain or incorporate by reference
forward-looking statements within the meaning of Section 27A of the